Trader consensus on Polymarket reflects a 70% implied probability that the CDC will not issue any Level 4 "Do Not Travel" warning by December 31, 2026, driven by the absence of active Level 4 notices and no escalations from lower-tier alerts in recent CDC surveillance. Official data shows zero Level 4 or even Level 3 designations currently, with the highest recent updates limited to Level 2 for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and global polio risks across 32 countries (early March), alongside a Level 1 dengue notice—all far below the life-threatening thresholds required for Level 4, such as widespread Ebola or novel pandemics. Epidemiological trends, including stable measles outbreaks (17 reported in 2026, mostly outbreak-associated) and no new avian influenza A(H5) human cases per FluView weeks 12-13, support this positioning amid inherent uncertainties from emerging pathogens; watch upcoming CDC weekly reports and WHO outbreak assessments for shifts.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गयासीडीसी ने 31 दिसंबर तक लेवल 4 की चेतावनी जारी कर दी है?
सीडीसी ने 31 दिसंबर तक लेवल 4 की चेतावनी जारी कर दी है?
हाँ
$70,008 वॉल्यूम
$70,008 वॉल्यूम
31 दिस, 2026
हाँ
$70,008 वॉल्यूम
$70,008 वॉल्यूम
31 दिस, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects a 70% implied probability that the CDC will not issue any Level 4 "Do Not Travel" warning by December 31, 2026, driven by the absence of active Level 4 notices and no escalations from lower-tier alerts in recent CDC surveillance. Official data shows zero Level 4 or even Level 3 designations currently, with the highest recent updates limited to Level 2 for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and global polio risks across 32 countries (early March), alongside a Level 1 dengue notice—all far below the life-threatening thresholds required for Level 4, such as widespread Ebola or novel pandemics. Epidemiological trends, including stable measles outbreaks (17 reported in 2026, mostly outbreak-associated) and no new avian influenza A(H5) human cases per FluView weeks 12-13, support this positioning amid inherent uncertainties from emerging pathogens; watch upcoming CDC weekly reports and WHO outbreak assessments for shifts.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
बाज़ार खुला: Jan 19, 2026, 3:15 PM ET
वॉल्यूम
$70,008समाप्ति तिथि
31 दिस, 2026बाज़ार खुला
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects a 70% implied probability that the CDC will not issue any Level 4 "Do Not Travel" warning by December 31, 2026, driven by the absence of active Level 4 notices and no escalations from lower-tier alerts in recent CDC surveillance. Official data shows zero Level 4 or even Level 3 designations currently, with the highest recent updates limited to Level 2 for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and global polio risks across 32 countries (early March), alongside a Level 1 dengue notice—all far below the life-threatening thresholds required for Level 4, such as widespread Ebola or novel pandemics. Epidemiological trends, including stable measles outbreaks (17 reported in 2026, mostly outbreak-associated) and no new avian influenza A(H5) human cases per FluView weeks 12-13, support this positioning amid inherent uncertainties from emerging pathogens; watch upcoming CDC weekly reports and WHO outbreak assessments for shifts.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
वॉल्यूम
$70,008समाप्ति तिथि
31 दिस, 2026बाज़ार खुला
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus on Polymarket reflects a 70% implied probability that the CDC will not issue any Level 4 "Do Not Travel" warning by December 31, 2026, driven by the absence of active Level 4 notices and no escalations from lower-tier alerts in recent CDC surveillance. Official data shows zero Level 4 or even Level 3 designations currently, with the highest recent updates limited to Level 2 for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and global polio risks across 32 countries (early March), alongside a Level 1 dengue notice—all far below the life-threatening thresholds required for Level 4, such as widespread Ebola or novel pandemics. Epidemiological trends, including stable measles outbreaks (17 reported in 2026, mostly outbreak-associated) and no new avian influenza A(H5) human cases per FluView weeks 12-13, support this positioning amid inherent uncertainties from emerging pathogens; watch upcoming CDC weekly reports and WHO outbreak assessments for shifts.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया
बाहरी लिंक से सावधान रहें।
बाहरी लिंक से सावधान रहें।
अक्सर पूछे जाने वाले प्रश्न